Free tool
Oncology stocks
We cover 2 companies grouped under the Oncology theme. The median market value in the group is $33.90M. Across the group, the median move over the past trading day is −2.63%. Price change over the past year runs from −72.1% to −31.7% across the middle 80 percent of the group, with a median of −51.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.